Disease Management Education for Liver Cancer Prevention

KB
Overseen ByKaren Basen-Engquist, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: M.D. Anderson Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new educational program to help individuals manage liver conditions like fibrosis (scarring) or steatosis (fatty liver) to prevent liver cancer. Participants will receive information on lifestyle changes, such as diet and exercise, through a series of text messages. The trial includes two groups: one will begin the Behavioral Intervention program immediately, while the other will start after six months. Individuals with liver issues who are overweight, have diabetes, or exhibit certain metabolic risks may be suitable candidates if they have a smartphone and can receive text messages. As an unphased trial, this study provides a unique opportunity to contribute to innovative educational approaches for liver health management.

Will I have to stop taking my current medications?

The trial information does not specify if you need to stop taking your current medications. However, it mentions that participants can be on specific drug treatments for conditions like high blood pressure, high triglycerides, or low HDL-cholesterol, so it seems likely that some medications may be continued.

What prior data suggests that this behavioral intervention is safe?

Research shows that the types of behavioral programs used in this trial are usually easy for people to handle. Studies on lifestyle changes indicate that these programs can lead to positive short-term health benefits without major safety issues. Reports have not indicated negative effects from these programs, as they mainly involve changes in diet, exercise, and health education.

Although these programs might not always result in permanent lifestyle changes, they are considered safe for participants. Evidence suggests that participants should not expect harmful side effects from taking part in these programs.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it focuses on a behavioral intervention for liver cancer prevention, offering a new angle compared to traditional methods like surgery, chemotherapy, or targeted therapy. This intervention emphasizes disease management education, aiming to empower participants with knowledge and strategies to prevent liver cancer through lifestyle changes. Unlike conventional treatments that address liver cancer after it develops, this approach seeks to reduce the risk proactively, which could lead to fewer cases and better outcomes in the long run. The trial's unique feature of offering both immediate and delayed interventions allows researchers to compare and understand the timing's impact on effectiveness, potentially refining future prevention strategies.

What evidence suggests that this trial's treatments could be effective for liver cancer prevention?

Research has shown that staying physically active can greatly reduce the risk of hepatocellular carcinoma (HCC), a common type of liver cancer. Regular exercise can lower the risk of HCC by about 30%. Programs that help people change their habits have demonstrated positive short-term results in reducing risk factors for liver diseases. This trial will compare two approaches: an immediate behavioral intervention and a delayed intervention. Although the long-term effects remain unclear, these programs are still important for maintaining liver health. Additionally, mobile health (mHealth) tools effectively share crucial information about preventing liver cancer. These findings suggest that changing behaviors can powerfully manage liver health and prevent cancer.678910

Who Is on the Research Team?

KB

Karen Basen-Engquist, MD

Principal Investigator

M.D. Anderson Cancer Center

Are You a Good Fit for This Trial?

Adults with liver fibrosis or steatosis and risk factors for cirrhosis, such as chronic hepatitis B or C, diabetes, high triglycerides, pre-diabetes, obesity, or metabolic abnormalities. Participants must be over 18 years old and able to communicate in English or Spanish. They need smartphone access but cannot join if pregnant, planning pregnancy soon, have exercise/diet restrictions due to medical conditions or surgery plans.

Inclusion Criteria

My tests show I have liver fibrosis or fat in my liver.

Exclusion Criteria

Medical contraindications to home-based exercise or low-fat, high-vegetable-and-fruit diet
Family or household member already enrolled into study
I have or had liver cancer or cancer that has spread to my liver.
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Immediate Intervention

Participants receive a 6-month self-management intervention to help implement behavioral changes to manage their disease

6 months

Delayed Intervention

Participants in the wait-list control group receive the intervention after their 6-month assessment

6 months

Follow-up

Participants are monitored for changes in fibrosis and behavioral risk factors after the intervention

6 months

What Are the Treatments Tested in This Trial?

Interventions

  • Behavioral Intervention
  • Control Group
Trial Overview The trial is testing a tailored disease management program that uses behavior modification to prevent liver cancer in patients at risk of developing cirrhosis. It involves two groups: one receiving the intervention and another serving as a control group without the special program.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: Arm 2: Delayed InterventionExperimental Treatment1 Intervention
Group II: Arm 1: Immediate InterventionExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

M.D. Anderson Cancer Center

Lead Sponsor

Trials
3,107
Recruited
1,813,000+

Cancer Prevention Research Institute of Texas

Collaborator

Trials
55
Recruited
98,900+

Published Research Related to This Trial

A randomized clinical trial involving 3,031 relatives of cancer patients showed that an educational intervention significantly reduced five cancer risk behaviors, including smoking, drinking, poor diet, unhealthy weight, and sun exposure, compared to a control group.
The intervention, based on social cognitive theories, led to a notable decrease in the Total Cancer Behavioral Risk (TCBR) indicator, suggesting that targeted educational efforts in primary care can effectively motivate families to adopt healthier behaviors and reduce cancer risk.
Impact of a primary care intervention on smoking, drinking, diet, weight, sun exposure, and work risk in families with cancer experience.López, ML., Iglesias, JM., del Valle, MO., et al.[2015]
Many cancer survivors continue to engage in risky health behaviors after diagnosis, which can increase the risk of cancer recurrence, but there is a growing trend towards receiving better risk-based medical care.
Informal education approaches, including diet, exercise, and cessation of unhealthy habits, have shown promise in improving the well-being and quality of life of cancer survivors, although more research is needed to confirm the long-term effectiveness of these interventions.
Informal education and health promoting approaches in adult cancer survivors.Argyriou, AA., Ifanti, AA., Kalofonos, H.[2012]
Behavioral interventions play a crucial role in managing side effects of cancer treatments, particularly in reducing nausea and vomiting caused by chemotherapy, which is a primary focus of current research.
These interventions are also being applied to alleviate other distressing symptoms such as anxiety and pain in both adult and pediatric cancer patients, highlighting their importance in comprehensive cancer care.
Advances in behavioral intervention in comprehensive cancer treatment.Redd, WH.[2019]

Citations

Lifestyle and Hepatocellular Carcinoma What Is the ...They showed that those who maintained PA levels over life had an approximately 30% reduction in HCC risk compared to those with consistently low PA. The ...
Lifestyle Behavior Interventions for Preventing Cancer in ...Interventions produced positive short-term results, but there was no evidence that behavioral modifications were sustained over time. All healthcare ...
Liver Cancer Prevention Randomized Control Trial | ...Primary objective: To test the effect of the behavioral intervention on fibrosis in a randomized trial.
mhealth-based interventions to improving liver cancer ...This study proposes a mHealth intervention based on the Fogg Behavioral Model to improve its effectiveness in disseminating information about LC ...
Liver cancer: A psychological CBT group intervention ...CBT interventions programme have shown efficacy and effectiveness on improving quality of life of patients. The expected outcomes of CBT ...
mhealth-based interventions to improving liver cancer ...This study proposes a mHealth intervention based on the Fogg Behavioral Model to improve its effectiveness in disseminating information about LC ...
Physical activity and exercise in liver cancerPhysical exercise should be considered an important intervention in the prevention and treatment of liver cancer and its complications.
Study Details | NCT06788353 | Prospective Collection of ...This trial is an observational clinical trial to explore the efficacy and safety of TACE combined targeting/immunotherapy for unresectable ...
Personalized Lifestyle Interventions for Prevention and ...This article calls for collaboration across the research, healthcare, and policy sectors to develop personalized lifestyle interventions.
Lifestyle Behavior Interventions for Preventing Cancer in ...The interventions explored showed that behavioral interventions promote positive short-term results, but they fail to promote long-term lifestyle modification.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security